Personal information

Romania

Activities

Employment (1)

Universitatea de Medicin? ?i Farmacie Carol Davila Facultatea de Medicin?: Bucuresti, RO

2014-10-01 to present (Pediatrics 1 - INSMC "Alessandrescu-Rusescu")
Employment
Source: Self-asserted source
Anca Balanescu

Education and qualifications (1)

Universitatea de Medicin? ?i Farmacie Carol Davila Facultatea de Medicin?: Bucuresti, RO

2004-10-01 to 2010-10-01 | MD
Education
Source: Self-asserted source
Anca Balanescu

Works (11)

Endocan and Lumican in Relation to Cardiometabolic Risk in a Pediatric Overweight and Obese Cohort: A Cross‐Sectional Study

BioMed Research International
2020-01 | Journal article
Contributors: Anca Bălănescu; Ioana Florentina Codreanu; Valentina Daniela Comanici; Iustina Violeta Stan; Eugenia Bălănescu; Paul Bălănescu; Ken-ichi Aihara
Source: check_circle
Crossref

Circulating Hsp90 Isoform Levels in Overweight and Obese Children and the Relation to Nonalcoholic Fatty Liver Disease: Results from a Cross-Sectional Study

Disease Markers
2019-12-03 | Journal article
Contributors: Anca Bălănescu; Iustina Stan; Ioana Codreanu; Valentina Comănici; Eugenia Bălănescu; Paul Bălănescu
Source: check_circle
Crossref

IL-17 and Th17 cells in systemic sclerosis: a comprehensive review

Romanian Journal of Internal Medicine
2017-07-08 | Journal article
Source: Self-asserted source
Anca Balanescu

Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review.

2016 | Journal article
Contributors: Lădaru A; Bălănescu P; Stan M; Codreanu I; Anca IA
Source: Self-asserted source
Anca Balanescu via Europe PubMed Central

Circulating Reticulocalbin 1 and Reticulocalbin 3 in Systemic Sclerosis Patients: Results of a Case Control Study.

2016 | Journal article
Contributors: Bălănescu P; Lădaru A; Bălănescu E; Pompilian V; Gologanu D; Caraiola S; Băicuş C; Dan GA
Source: Self-asserted source
Anca Balanescu via Europe PubMed Central

Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study.

2016-09 | Journal article
Contributors: Bălănescu P; Lădaru A; Bălănescu E; Voiosu T; Băicuş C; Dan GA
Source: Self-asserted source
Anca Balanescu via Europe PubMed Central

IL-17, IL-6 and IFN-γ in Systemic Sclerosis Patients.

2015 | Journal article
Contributors: Bălănescu P; Lădaru A; Bălănescu E; Nicolau A; Băicuş C; Dan GA
Source: Self-asserted source
Anca Balanescu via Europe PubMed Central

Association of anti phosphatidyl ethanolamine antibodies and low complement levels in systemic sclerosis patients--results of a cross-sectional study.

2015-10 | Journal article
Contributors: Bălănescu P; Lădaru A; Bălănescu E; Băicuş C; Dan GA
Source: Self-asserted source
Anca Balanescu via Europe PubMed Central

Serum endocan levels are increased in patients with inflammatory bowel disease.

2014 | Journal article
Contributors: Voiosu T; Bălănescu P; Benguş A; Voiosu A; Baicuş CR; Barbu M; Ladaru A; Nitipir C; Mateescu B; Diculescu M et al.
Source: Self-asserted source
Anca Balanescu via Europe PubMed Central

Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review.

2014-08 | Journal article
Contributors: Bălănescu P; Lădaru A; Bălănescu E; Băicuş C; Dan GA
Source: Self-asserted source
Anca Balanescu via Europe PubMed Central

Th17 and IL-17 immunity in chronic hepatitis C infection.

2012 | Journal article
Contributors: Bălănescu P; Lădaru A; Voiosu T; Nicolau A; Ene M; Bălănescu E
Source: Self-asserted source
Anca Balanescu via Europe PubMed Central

Peer review (5 reviews for 1 publication/grant)

Review activity for Nutrition & metabolism. (5)